MedPath

PHARMABIOTIX, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome With Diarrhea
First Posted Date
2015-05-01
Last Posted Date
2020-06-12
Lead Sponsor
Pharmabiotix Inc
Target Recruit Count
50
Registration Number
NCT02431533
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.